CCM
Camber Capital Management Portfolio holdings
AUM
$718M
This Quarter Return
-2.87%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$2.59B
AUM Growth
+$2.59B
(-9.4%)
Cap. Flow
-$129M
Cap. Flow
% of AUM
-4.97%
Top 10 Holdings %
Top 10 Hldgs %
61.37%
Holding
42
New
6
Increased
7
Reduced
9
Closed
5
Top Buys
| 1 |
Humana
HUM
|
$149M |
| 2 |
CVS Health
CVS
|
$88.6M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$70M |
| 4 |
Medtronic
MDT
|
$31.5M |
| 5 |
argenx
ARGX
|
$31M |
Top Sells
| 1 |
Tenet Healthcare
THC
|
$200M |
| 2 |
Biogen
BIIB
|
$86.3M |
| 3 |
Sarepta Therapeutics
SRPT
|
$68.7M |
| 4 |
Universal Health Services
UHS
|
$55.5M |
| 5 |
Myriad Genetics
MYGN
|
$52.2M |
Sector Composition
| 1 | Healthcare | 97.64% |
| 2 | Consumer Staples | 1.46% |
| 3 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Zimmer Biomet
ZBH
$21B
| $209M | 5.78% | 1,925,000 | – | – |
|
2
Baxter International
BAX
$12.7B
| $184M | 5.09% | 5,500,000 +500,000 | +10% | +$16.7M |
|
|
3
Medtronic
MDT
$119B
| $177M | 4.9% | 2,250,000 +400,000 | +22% | +$31.5M |
|
|
4
Universal Health Services
UHS
$11.6B
| $176M | 4.86% | 950,000 -300,000 | -24% | -$55.5M |
|
5
Globus Medical
GMED
$8.27B
| $171M | 4.74% | 2,500,000 | – | – |
|
6
Viatris
VTRS
$12.3B
| $159M | 4.41% | 15,000,000 -1,250,000 | -8% | -$13.3M |
|
|
7
Humana
HUM
$36.5B
| $149M | 4.14% | +400,000 | New | +$149M |
|
|
8
Myriad Genetics
MYGN
$593M
| $135M | 3.72% | 5,500,000 -2,135,000 | -28% | -$52.2M |
|
9
Jazz Pharmaceuticals
JAZZ
$7.75B
| $123M | 3.4% | 1,150,000 | – | – |
|
10
PTC Therapeutics
PTCT
$3.92B
| $107M | 2.96% | 3,500,000 -500,000 | -13% | -$15.3M |
|
11
Brookdale Senior Living
BKD
$1.83B
| $106M | 2.93% | 15,500,000 | – | – |
|
12
GSK
GSK
$79.9B
| $103M | 2.85% | 2,675,000 +500,000 | +23% | +$19.3M |
|
|
13
BioMarin Pharmaceuticals
BMRN
$11.2B
| $90.6M | 2.51% | 1,100,000 +850,000 | +340% | +$70M |
|
14
Select Medical
SEM
$1.61B
| $89.4M | 2.47% | 2,550,000 -850,000 | -25% | -$29.8M |
|
|
15
CVS Health
CVS
$92.8B
| $88.6M | 2.45% | +1,500,000 | New | +$88.6M |
|
|
WBA
16
DELISTED
Walgreens Boots Alliance
WBA
| $84.7M | 2.34% | 7,000,000 -800,000 | -10% | -$9.68M |
|
17
Qiagen
QGEN
$10.1B
| $61.6M | 1.71% | 1,500,000 +290,000 | +24% | +$11.9M |
|
18
ZimVie
ZIMV
$532M
| $59.3M | 1.64% | 3,250,000 | – | – |
|
19
Denali Therapeutics
DNLI
$2.23B
| $46.4M | 1.29% | 2,000,000 +500,000 | +33% | +$11.6M |
|
20
Perrigo
PRGO
$3.27B
| $39M | 1.08% | 1,520,000 | – | – |
|
21
Herbalife
HLF
$1.01B
| $31.2M | 0.86% | 3,000,000 | – | – |
|
|
22
argenx
ARGX
$43.6B
| $31M | 0.86% | +72,000 | New | +$31M |
|
|
23
Sarepta Therapeutics
SRPT
$1.78B
| $23.7M | 0.66% | 150,000 -435,000 | -74% | -$68.7M |
|
|
BKDT
24
DELISTED
Brookdale Senior Living Inc. 7.00% Tangible Equity Units
BKDT
| $23.2M | 0.64% | 250,000 | – | – |
|
|
BCYC
25
Bicycle Therapeutics
BCYC
$511M
| $18.5M | 0.51% | 915,000 +465,000 | +103% | +$9.41M |
|